Senores Pharmaceuticals Complete Financial Statements
SENORES • Review detailed financials to uncover trends, confirm thesis & journal trades
4 Years of Data
2025 - 2022
Complete Financial Data Export
Export complete financial statements for Senores Pharmaceuticals (SENORES).
Downloads include all available records across all periods.
For market performance, see the
SENORES stock price today
.
Profitability Ratios
Net Profit Margin
18.87%
2025 data
EBITDA Margin
29.56%
2025 data
Operating Margin
27.00%
2025 data
Return on Assets
2.44%
2025 data
Return on Equity
3.69%
2025 data
Balance Sheet Ratios
Current Ratio
4.15
2025 data
Debt to Equity
1.51
2025 data
Equity Ratio
66.18%
2025 data
Asset Turnover
0.13
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+59.0%
Year-over-Year
Net Profit Growth
+130.8%
Year-over-Year
EBITDA Growth
+104.3%
Year-over-Year
Expense Growth
+45.5%
Year-over-Year
Assets Growth
+97.3%
Year-over-Year
Equity Growth
+250.0%
Year-over-Year
Liabilities Growth
+97.3%
Year-over-Year
Operating Cash Flow Growth
-76.9%
Year-over-Year
Investing Cash Flow Growth
-696.3%
Year-over-Year
Financing Cash Flow Growth
+558.6%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 159 | 117 | 134 | 100 | 104 | 80 | 108 | 80 |
| Expenses | 112 | 95 | 104 | 77 | 80 | 59 | 77 | 64 |
| EBITDA | 47 | 22 | 30 | 23 | 24 | 21 | 31 | 16 |
| Operating Profit Margin % | 27.00% | 10.00% | 20.00% | 21.00% | 22.00% | 26.00% | 25.00% | 19.00% |
| Depreciation | 8 | 5 | 6 | 4 | 4 | 4 | 4 | 3 |
| Interest | 6 | 5 | 5 | 5 | 3 | 5 | 6 | 3 |
| Profit Before Tax | 41 | 21 | 27 | 16 | 18 | 14 | 21 | 10 |
| Tax | 11 | 3 | 5 | 3 | 3 | 3 | 4 | 3 |
| Net Profit | 30 | 18 | 21 | 13 | 14 | 11 | 16 | 7 |
| Earnings Per Share (₹) | 6.54 | 3.81 | 4.60 | 3.92 | 8.03 | 3.39 | 5.04 | 4.01 |
Related Pages for Senores Pharmaceuticals
Additional stock information and data for SENORES
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| Total Assets | 1,227 | 622 | 131 | 59 |
| Current Assets | 722 | 251 | 51 | 27 |
| Fixed Assets | 301 | 235 | 27 | 7 |
| Capital Work in Progress | 173 | 97 | 35 | 8 |
| Investments | 0 | 0 | 17 | 15 |
| Other Assets | 754 | 289 | 53 | 29 |
| LIABILITIES | ||||
| Total Liabilities | 1,227 | 622 | 131 | 59 |
| Current Liabilities | 174 | 143 | 34 | 13 |
| Non-Current Liabilities | ||||
| SHAREHOLDERS' EQUITY | ||||
| Total Equity | 812 | 232 | 46 | 37 |
| Share Capital | 46 | 31 | 10 | 9 |
| Reserves & Surplus | 740 | 174 | 36 | 28 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 |
|---|---|---|---|---|
| Operating Activities | -46 | -26 | -1 | -10 |
| Investing Activities | -430 | -54 | -48 | -24 |
| Financing Activities | 573 | 87 | 46 | 37 |
| Net Cash Flow | 98 | 8 | -3 | 2 |